RVMD
The table below shows Revolution Medicines, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $383.75M | $543.06M | $696.15M | $161.41M | $108.50M | $104.27M |
| Short-term investments | $1.64B | $1.75B | $1.16B | $483.53M | $468.56M | $336.47M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.08B |
| $2.33B |
| $1.88B |
| $660.18M |
| $589.77M |
| $454.12M |
| Property, plant & equipment | $33.19M | $24.29M | $22.86M | $18.66M | $11.54M | $8.90M |
| Goodwill | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
| Total assets | $2.35B | $2.56B | $2.06B | $811.93M | $737.99M | $567.40M |
| Accounts payable | $64.62M | $54.43M | $61.79M | $21.31M | $14.06M | $12.61M |
| Total current liabilities | $290.42M | $163.91M | $143.85M | $61.98M | $60.35M | $47.18M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $723.21M | $293.10M | $235.51M | $126.74M | $135.42M | $92.72M |
| Retained earnings | -$2.87B | -$1.74B | -$1.14B | -$701.34M | -$452.64M | -$265.55M |
| Total equity | $1.63B | $2.27B | $1.83B | $685.19M | $602.57M | $474.68M |